Results 51 to 60 of about 17,078 (163)

Long-term safety, efficacy, and tolerability of imidafenacin in the treatment of overactive bladder: a review of the Japanese literature

Patient Preference and Adherence, 2013
Naoya MasumoriDepartment of Urology, Sapporo Medical University School of Medicine, Sapporo, JapanAbstract: Imidafenacin is an antimuscarinic agent with high affinity for the M3 and M1 muscarinic receptor subtypes and low affinity for the M2 subtype, and
Masumori N
doaj  

Comparison of the effects of transcranial direct current stimulation and transcutaneous tibial nerve stimulation on the urgency and frequency of women with overactive bladder syndrome: study protocol of a randomized clinical trial

Trials
Background Overactive bladder syndrome is common, with a prevalence of 12–17% among adults. Posterior tibial nerve stimulation is the primary nonpharmacological and conservative treatment for overactive bladder syndrome. While several human brain imaging
Zahra Gorji, MohammadReza Hadian Rasanani, Michael Nitsche, Tannaz Ahadi, Roya Khanmohammadi, Mona Gorji, Roxana Bazaz Behbahani, Vahid Rafiei Manesh   +7 more
doaj   +1 more source

The Relationship of The Incident o Metabolic Syndrome and Overactive Bladder in Female Patients at DR. M. Djamil Padang in 2023

Andalas Obstetrics and Gynecology Journal
Overactive Bladder (OAB) is a chronic medical condition that has a negative impact on an individual's health and quality of life. Cardiovascular problems are considered to be one of the risks associated with OAB where one of the higher cardiovascular ...
Anggra Pramana, Bobby Indra Utama, Husna Yetti   +2 more
doaj   +1 more source

Overactive bladder: strategies to ensure treatment compliance and adherence

Clinical Interventions in Aging, 2016
Prabhpreet Dhaliwal, Adrian Wagg Department of Medicine, University of Alberta, Edmonton, Canada Abstract: Overactive bladder is a common, debilitating condition for many patients who may benefit from pharmacological management of their condition ...
Dhaliwal P, Wagg A
doaj  

Mirabegron – a selective ß3-adrenoreceptor agonist for the treatment of overactive bladder

Research and Reports in Urology, 2012
Alka A Bhide, G Alessandro Digesu, Ruwan Fernando, Vik KhullarDepartment of Urogynaecology, St Mary's Hospital, London, United KingdomAbstract: Overactive bladder is a common condition that significantly impacts overall quality of life ...
Bhide AB, Digesu GA, Fernando R, Khullar V   +3 more
doaj  

Mirabegron for overactive bladder. [PDF]

Can Fam Physician
Falk J, Lane J, Kim T, Chan K.
europepmc   +1 more source

Navigating the challenges of overactive bladder management in women. [PDF]

World J Urol
Braga A, Goldman HB, Padoa A, Serati M.
europepmc   +1 more source

Chemodenervation Use for Overactive Bladder in Female Medicare Beneficiaries. [PDF]

Urogynecology (Phila)
Ringel NE, Ringel NE, Scales CD, Ford CB, Bretschneider CE, Enemchukwu E, Handa VL.   +6 more
europepmc   +1 more source

Chinese American Women's Overactive Bladder Care Experience: A Qualitative Study. [PDF]

Urogynecology (Phila)
Mou T, Su GS, Wong JB, Collins S, Kenton K, Paasche-Orlow MK.   +5 more
europepmc   +1 more source

Health Disparities and Overactive Bladder: Bridging the Gap. [PDF]

Curr Bladder Dysfunct Rep
Gunamany S, Hartt A, Kopkin R, Omole I, Enemchukwu EA.   +4 more
europepmc   +1 more source